Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Sleat, David E.
Sohar, Istvan
Gin, Rosalie M.
and
Lobel, Peter
2001.
Aminoglycoside-mediated suppression of nonsensemutations in late infantile neuronal ceroid lipofuscinosis.
European Journal of Paediatric Neurology,
Vol. 5,
Issue. ,
p.
57.
Cassan, Michel
and
Rousset, Jean-Pierre
2001.
UAG readthrough in mammalian cells: Effect of upstream and downstream stop codon contexts reveal different signals.
BMC Molecular Biology,
Vol. 2,
Issue. 1,
Namy, Olivier
Hatin, Isabelle
Stahl, Guillaume
Liu, Hongmei
Barnay, Stephanie
Bidou, Laure
and
Rousset, Jean-Pierre
2002.
Gene Overexpression as a Tool for Identifying New trans-Acting Factors Involved in Translation Termination in Saccharomyces cerevisiae
.
Genetics,
Vol. 161,
Issue. 2,
p.
585.
Steinitz, Benjamin
Gafni, Yedidya
Cohen, Yael
Perea Diaz, Josefina
Tabib, Yona
Levski, Shlomit
and
Navon, Amos
2002.
Insecticidal activity of a cryia(c) transgene in callus derived from regeneration-recalcitrant cotton (Gossypium hirsutum L.).
In Vitro Cellular & Developmental Biology - Plant,
Vol. 38,
Issue. 3,
p.
247.
Nguyen, Tung X
Cole, Alex M
and
Lehrer, Robert I
2003.
Evolution of primate θ-defensins: a serpentine path to a sweet tooth.
Peptides,
Vol. 24,
Issue. 11,
p.
1647.
Zeitlin, Pamela L
2003.
Emerging drug treatments for cystic fibrosis.
Expert Opinion on Emerging Drugs,
Vol. 8,
Issue. 2,
p.
523.
Peters, Melanie
Ermert, Saskia
Jeck, Nikola
Derst, Christian
Pechmann, Ulla
Weber, Stefanie
Schlingmann, Karl P.
Seyberth, Hannsjoerg W.
Waldegger, Siegfried
and
Konrad, Martin
2003.
Classification and rescue of ROMK mutations underlying hyperprostaglandin E syndrome/antenatal Bartter syndrome.
Kidney International,
Vol. 64,
Issue. 3,
p.
923.
Kerem, Eitan
2004.
Pharmacologic therapy for stop mutations: how much CFTR activity is enough?.
Current Opinion in Pulmonary Medicine,
Vol. 10,
Issue. 6,
p.
547.
Xi, Biao
Guan, Fangxia
and
Lawrence, David S.
2004.
Enhanced Production of Functional Proteins from Defective Genes.
Journal of the American Chemical Society,
Vol. 126,
Issue. 18,
p.
5660.
Howard, Michael T.
Anderson, Christine B.
Fass, Uwe
Khatri, Shikha
Gesteland, Raymond F.
Atkins, John F.
and
Flanigan, Kevin M.
2004.
Readthrough of dystrophin stop codon mutations induced by aminoglycosides.
Annals of Neurology,
Vol. 55,
Issue. 3,
p.
422.
Sangkuhl, Katrin
Schulz, Angela
Römpler, Holger
Yun, June
Wess, Jürgen
and
Schöneberg, Torsten
2004.
Aminoglycoside-mediated rescue of a disease-causing nonsense mutation in the V2 vasopressin receptor gene in vitro and in vivo.
Human Molecular Genetics,
Vol. 13,
Issue. 9,
p.
893.
Lai, Chih-Hung
Chun, Helen H.
Nahas, Shareef A.
Mitui, Midori
Gamo, Kristin M.
Du, Liutao
and
Gatti, Richard A.
2004.
Correction of ATM gene function by aminoglycoside-induced read-through of premature termination codons.
Proceedings of the National Academy of Sciences,
Vol. 101,
Issue. 44,
p.
15676.
Bidou, L
Hatin, I
Perez, N
Allamand, V
Panthier, J-J
and
Rousset, J-P
2004.
Premature stop codons involved in muscular dystrophies show a broad spectrum of readthrough efficiencies in response to gentamicin treatment.
Gene Therapy,
Vol. 11,
Issue. 7,
p.
619.
Kulyté, Agné
Dryselius, Rikard
Karlsson, Jenny
and
Good, Liam
2005.
Gene selective suppression of nonsense termination using antisense agents.
Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression,
Vol. 1730,
Issue. 3,
p.
165.
Kerem, Eitan
2005.
Pharmacological induction of CFTR function in patients with cystic fibrosis: mutation-specific therapy.
Pediatric Pulmonology,
Vol. 40,
Issue. 3,
p.
183.
Namy, Olivier
Lecointe, François
Grosjean, Henri
and
Rousset, Jean-Pierre
2005.
Fine-Tuning of RNA Functions by Modification and Editing.
Vol. 12,
Issue. ,
p.
309.
Mattis, Virginia B.
Rai, Ravi
Wang, Jinhua
Chang, Cheng-Wei T.
Coady, Tristan
and
Lorson, Christian L.
2006.
Novel aminoglycosides increase SMN levels in spinal muscular atrophy fibroblasts.
Human Genetics,
Vol. 120,
Issue. 4,
p.
589.
Yorgason, Joshua G
Fayad, Jose N
and
Kalinec, Federico
2006.
Understanding drug ototoxicity: molecular insights for prevention and clinical management.
Expert Opinion on Drug Safety,
Vol. 5,
Issue. 3,
p.
383.
Schroers, A.
Kley, R. A.
Stachon, A.
Horvath, R.
Lochmüller, H.
Zange, J.
and
Vorgerd, M.
2006.
Gentamicin treatment in McArdle disease: Failure to correct myophosphorylase deficiency.
Neurology,
Vol. 66,
Issue. 2,
p.
285.
Brooks, Doug A.
Muller, Viv J.
and
Hopwood, John J.
2006.
Stop-codon read-through for patients affected by a lysosomal storage disorder.
Trends in Molecular Medicine,
Vol. 12,
Issue. 8,
p.
367.